About Viva Biotech
Viva Biotech is a company based in Shanghai (China) founded in 2006.. The company has 2,060 employees as of December 31, 2024. Viva Biotech has completed 2 acquisitions, including SYNthesis Med Chem and Zhejiang Langhua Pharmaceutical. Viva Biotech operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
- Headquarter Shanghai, China
- Employees 2060 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Viva Biotech Holdings
-
Annual Revenue
$276.83 M (USD)-9.57as on Dec 31, 2024
-
Net Profit
$23.35 M (USD)0as on Dec 31, 2024
-
EBITDA
$61.92 M (USD)7.75as on Dec 31, 2024
-
Latest Funding Round
-
Investors
Temasek
& 1 more
-
Employee Count
2060
as on Dec 31, 2024
-
Investments & Acquisitions
SYNthesis Med Chem
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Viva Biotech
Viva Biotech is a publicly listed company on the HKEX with ticker symbol 1873 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Viva Biotech
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Post-IPO - Viva Biotech | Valuation |
investors |
|
| Jan, 2020 | Amount | Post-IPO - Viva Biotech | Valuation |
investors |
|
| Jun, 2017 | Amount | Series A - Viva Biotech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Viva Biotech
Viva Biotech has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Temasek and Viva Ventures Biotech Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An investment platform is provided for diverse sectors and geographies.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Viva Biotech
Viva Biotech has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include SYNthesis Med Chem and Zhejiang Langhua Pharmaceutical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of small molecule drug discovery services for single compound synthesis
|
2007 | ||||
|
Pharmaceutical raw materials, intermediates, and finished drugs are contract manufactured.
|
1986 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Viva Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Viva Biotech Comparisons
Competitors of Viva Biotech
Viva Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery and development services are provided to biopharma sector.
|
|
| domain | founded_year | HQ Location |
Cancer and CVMD drugs are developed using PDX models.
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided for therapeutic development.
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided to pharmaceutical clients worldwide.
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided to the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Viva Biotech
Frequently Asked Questions about Viva Biotech
When was Viva Biotech founded?
Viva Biotech was founded in 2006 and raised its 1st funding round 11 years after it was founded.
Where is Viva Biotech located?
Viva Biotech is headquartered in Shanghai, China.
How many employees does Viva Biotech have?
As of Dec 31, 2024, the latest employee count at Viva Biotech is 2,060.
What is the annual revenue of Viva Biotech?
Annual revenue of Viva Biotech is $276.83M as on Dec 31, 2024.
What does Viva Biotech do?
Viva Biotech was established in 2006 and is based in Shanghai, China. Operations as a multidisciplinary contract research organization center on drug discovery and development within the biotechnology sector. Services encompass gene-to-protein and gene-to-structure processes, GPCR-targeted drug discovery, antibody therapeutics development, fragment-based screening, medicinal chemistry, in vivo and translational pharmacology, in vitro pharmacology, DMPK studies, protein analysis, and crystallography.
Who are the top competitors of Viva Biotech?
Viva Biotech's top competitors include Evotec, Crown Bioscience and NIH.
Is Viva Biotech publicly traded?
Yes, Viva Biotech is publicly traded on HKEX under the ticker symbol 1873.
How many acquisitions has Viva Biotech made?
Viva Biotech has made 2 acquisitions, including SYNthesis Med Chem, and Zhejiang Langhua Pharmaceutical.
Who are Viva Biotech's investors?
Viva Biotech has 2 investors. Key investors include Temasek, and Viva Ventures Biotech Fund.
What is Viva Biotech's ticker symbol?
The ticker symbol of Viva Biotech is 1873 on HKEX.